Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Correlations between ACE single nucleotide polymorphisms and prognosis of patients with septic shock.

Dou XM, Cheng HJ, Meng L, Zhou LL, Ke YH, Liu LP, Li YM.

Biosci Rep. 2017 Apr 28;37(2). pii: BSR20170145. doi: 10.1042/BSR20170145. Print 2017 Apr 30.

2.

Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.

Allou N, Bouteau A, Allyn J, Snauwaert A, Valance D, Jabot J, Bouchet B, Galliot R, Corradi L, Montravers P, Augustin P.

Ann Intensive Care. 2016 Dec;6(1):106. Epub 2016 Nov 2.

3.

Right first time!

Alp E.

Ann Transl Med. 2016 Sep;4(17):331. Review.

4.

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL.

Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.

PMID:
27418577
5.

Advances in antibiotic therapy in the critically ill.

Vincent JL, Bassetti M, François B, Karam G, Chastre J, Torres A, Roberts JA, Taccone FS, Rello J, Calandra T, De Backer D, Welte T, Antonelli M.

Crit Care. 2016 May 17;20(1):133. doi: 10.1186/s13054-016-1285-6. Review.

6.

Intensive care for cancer patients: An interdisciplinary challenge for cancer specialists and intensive care physicians.

Schellongowski P, Kiehl M, Kochanek M, Staudinger T, Beutel G; Intensive Care in Hematologic-Oncologic Patients (iCHOP)..

Memo. 2016;9:39-44. Epub 2016 Mar 8. Review.

7.

In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia.

Cha MK, Kang CI, Kim SH, Cho SY, Ha YE, Wi YM, Chung DR, Peck KR, Song JH; Korean Network for Study on Infectious Diseases (KONSID)..

Antimicrob Agents Chemother. 2015 Sep;59(9):5834-7. doi: 10.1128/AAC.01121-15. Epub 2015 Jun 29.

8.

Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Liang SY, Kumar A.

Curr Infect Dis Rep. 2015 Jul;17(7):493. doi: 10.1007/s11908-015-0493-6.

9.

The Japanese guidelines for the management of sepsis.

Oda S, Aibiki M, Ikeda T, Imaizumi H, Endo S, Ochiai R, Kotani J, Shime N, Nishida O, Noguchi T, Matsuda N, Hirasawa H; Sepsis Registry Committee of The Japanese Society of Intensive Care Medicine..

J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.

10.

Treatment of bloodstream infections in ICUs.

Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, Sonneville R, Mariotte E, Bouadma L, Wolff M.

BMC Infect Dis. 2014 Nov 28;14:489. doi: 10.1186/1471-2334-14-489. Review.

11.

How to approach and treat VAP in ICU patients.

Borgatta B, Rello J.

BMC Infect Dis. 2014 Apr 30;14:211. doi: 10.1186/1471-2334-14-211.

12.

Antibiotic stewardship in the intensive care unit.

Luyt CE, Bréchot N, Trouillet JL, Chastre J.

Crit Care. 2014 Aug 13;18(5):480. doi: 10.1186/s13054-014-0480-6. Review.

13.

Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.

Frickmann H, Masanta WO, Zautner AE.

Biomed Res Int. 2014;2014:375681. doi: 10.1155/2014/375681. Epub 2014 Sep 17. Review.

14.

Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock.

Picard W, Bazin F, Clouzeau B, Bui HN, Soulat M, Guilhon E, Vargas F, Hilbert G, Bouchet S, Gruson D, Moore N, Boyer A.

Antimicrob Agents Chemother. 2014 Dec;58(12):7468-74. doi: 10.1128/AAC.03750-14. Epub 2014 Oct 6.

15.

The Autodigestion Hypothesis in Shock and Multi-Organ Failure: Degrading Protease Activity.

Schmid-Schönbein GW, Penn A, Kistler E.

Bol Soc Port Hemorreol Microcirc. 2011 Jul;26(3):6-15.

16.

Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.

Tängdén T.

Ups J Med Sci. 2014 May;119(2):149-53. doi: 10.3109/03009734.2014.899279. Epub 2014 Mar 26. Review.

17.

Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.

Skorup P, Maudsdotter L, Lipcsey M, Castegren M, Larsson A, Jonsson AB, Sjölin J.

PLoS One. 2014 Feb 28;9(2):e90441. doi: 10.1371/journal.pone.0090441. eCollection 2014.

18.

The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.

Pop-Vicas A, Opal SM.

Virulence. 2014 Jan 1;5(1):206-12. doi: 10.4161/viru.26210. Epub 2013 Aug 27. Review.

19.

An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Kumar A.

Virulence. 2014 Jan 1;5(1):80-97. doi: 10.4161/viru.26913. Epub 2013 Nov 1. Review.

20.

Point-of-Care Testing at the Disaster-Emergency-Critical Care Interface.

Tran NK, Godwin Z, Bockhold J.

Point Care. 2012 Dec 1;11(4):180-183.

Supplemental Content

Support Center